Sign up to save your podcasts
Or
Share How the New Role of the CRO Affects Patient Enrollment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How the New Role of the CRO Affects Patient Enrollment
Thought Leader: Richard Malcolm, CEO, Acurian In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
View all episodes
By Daniel LimbachThought Leader: Richard Malcolm, CEO, Acurian In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.